These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3147546)

  • 21. ["There are clear criteria for product surveillance studies"].
    Throm S
    MMW Fortschr Med; 2009 Aug; 151(34-35):7. PubMed ID: 19771777
    [No Abstract]   [Full Text] [Related]  

  • 22. Statewide test of a new postmarketing drug surveillance system.
    Fisher S; Bryant SG; Solovitz BL; Kluge RM
    Tex Med; 1987 Aug; 83(8):59-62. PubMed ID: 3660262
    [No Abstract]   [Full Text] [Related]  

  • 23. [Medication administration errors in a pediatric intensive care unit].
    Steckmeyer C; Henn-Ménétré S; Le Tacon S; May I
    Arch Pediatr; 2007 Aug; 14(8):971-7. PubMed ID: 17442545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scientific challenges in postmarketing surveillance of ocular adverse drug reactions.
    Fraunfelder FW; Fraunfelder FT
    Am J Ophthalmol; 2007 Jan; 143(1):145-149. PubMed ID: 17188050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procedures and methods of benefit assessments for medicines in Germany: give the child a name.
    Schünemann H; Kunz R; Falck-Ytter Y; Santesso N
    Eur J Health Econ; 2009 May; 10(2):237-8. PubMed ID: 19290557
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug effects in elderly subjects: from the pharmacologic target to the risk-benefit. Round Table #5 of the 16th National Clinical Pharmacology Workshop].
    Lassale C; Piette F; Jolliet P
    Therapie; 2001; 56(4):363-7. PubMed ID: 11677853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physician and pharmaceutical industry. II. Postmarketing surveillance].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1992 Jan; 136(1):36-41. PubMed ID: 1728761
    [No Abstract]   [Full Text] [Related]  

  • 28. Monitoring adverse drug reactions in the postmarketing phase.
    Hoigné R; Hottinger S
    Pharm Acta Helv; 1988; 63(1):2-12. PubMed ID: 3283774
    [No Abstract]   [Full Text] [Related]  

  • 29. [Seventh French Drug Surveillance Seminar. Caen, 21-22 November 1985].
    Therapie; 1986; 41(5):323-84. PubMed ID: 3810518
    [No Abstract]   [Full Text] [Related]  

  • 30. [Eighth French Drug Surveillance Seminar. Paris, 23-24 October 1986].
    Therapie; 1987; 42(4):331-410. PubMed ID: 3686465
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cutaneous side-effects in drug assessment].
    Jean-Pastor MJ
    Therapie; 2002; 57(3):265-8. PubMed ID: 12422540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Look-alike, sound-alike drug names.
    Jt Comm Perspect; 2001 Jul; 21(7):10-1. PubMed ID: 11467264
    [No Abstract]   [Full Text] [Related]  

  • 33. [Is imputation in drug surveillance reliable?].
    Girard M
    Therapie; 1984; 39(3):291-6. PubMed ID: 6463954
    [No Abstract]   [Full Text] [Related]  

  • 34. [Privacy and drug surveillance: a study of the viewpoints of medication users].
    de Wit ME; Stricker BH; Porsius AJ
    Ned Tijdschr Geneeskd; 1996 Oct; 140(40):1989-92. PubMed ID: 8965928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Family practice residencies in community health centers--an approach to cost and access concerns.
    Zweifler J
    Public Health Rep; 1995; 110(3):312-8. PubMed ID: 7610223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causes of therapeutic errors in older adults: evaluation of National Poison Center data.
    Hayes BD; Klein-Schwartz W; Gonzales LF
    J Am Geriatr Soc; 2009 Apr; 57(4):653-8. PubMed ID: 19220563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [6th French seminar on drug surveillance. Clermont-Ferrand, 22-23 November 1984].
    Therapie; 1985; 40(5):287-376. PubMed ID: 4095682
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug safety. Notes about surveillance].
    Moreno Alvarez PJ; Madurga Sanz M
    Farm Hosp; 2004; 28(3):225-8. PubMed ID: 15222877
    [No Abstract]   [Full Text] [Related]  

  • 39. [Regulatory guidelines and drug safety].
    Flury W
    Ther Umsch; 1993 Jan; 50(1):49-51. PubMed ID: 8378867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The "Z" word.
    Fraterrigo CC; Frangella GM
    Am J Hosp Pharm; 1994 Jan; 51(2):235. PubMed ID: 8160675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.